(Reuters) -Louisiana Attorney General Liz Murrill said on Tuesday she had filed three separate lawsuits against CVS for unfair, deceptive and unlawful practices "that have harmed Louisiana ...

A Louisiana law firm filed a lawsuit against CVS after the company sent mass texts and emails to customers urging them to ask their representatives to oppose a state bill.

“Today, I have filed multiple lawsuits against CVS Health Corp, CaremarkPCS Health, LLC, and their affiliated entities for unfair, deceptive, and unlawful practices that have harmed Louisiana ...

NEW ORLEANS (AP) — Louisiana filed several lawsuits accusing pharmaceutical giant CVS of abusing customer information and using its dominant market position to drive up drug costs and unfairly ...

(The Center Square) — CVS Health is pushing back against claims from Louisiana Attorney General Liz Murrill and Gov. Jeff Landry that the company engaged in deceptive, anticompetitive practices ...

Louisiana Gov. Jeff Landry and Attorney General Liz Murrill announced Tuesday the state is filing three lawsuits against CVS and its affiliates alleging they engaged in “ unfair, deceptive, and ...

Landry, Murrill announce ‘major legal action,’ 3 new lawsuits against CVS by: Scott Yoshonis. Posted: Jun 24, 2025 / 01:46 PM CDT. ... deceptive, and unlawful practices.” ...

The claims come from the nonprofit organization Center for Inquiry (CFI), which filed nearly identical lawsuits against CVS and Walmart in 2018 and 2019, respectively, to try to boot homeopathic ...

June 24 (Reuters) - Louisiana Attorney General Liz Murrill said on Tuesday she had filed three separate lawsuits against CVS , opens new tab for unfair, deceptive and unlawful practices "that have ...

Another lawsuit argues that CVS uses its market control to exclude lower-cost drugs for “high-rebate, high-price brand drugs” and other practices that “distort the drug market” and “drive up costs for ...

NEW ORLEANS (AP) — Louisiana filed several lawsuits accusing pharmaceutical giant CVS of abusing customer information and using its dominant market position to drive up drug costs and unfairly ...